Open-label crossover study for the efficacy of Escitalopram and Mecobalamin for patients with tinnitus.
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2018
Price : $35 *
At a glance
- Drugs Escitalopram (Primary) ; Mecobalamin (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- 29 Jan 2018 Status changed from recruiting to completed.
- 14 Apr 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 03 Jun 2014 New trial record